PRF Technologies Ltd.
PRFXHealthcare|Drug Manufacturers - Specialty & Generic|IL
$0.87
+0.11 (+14.77%)
DCF Value
$6.39
Tangible Book / Share
$7.51
Cash / Share
$9.27
Financials
Financial Snapshot
Market Cap
$70.1K
Enterprise Value
-$8.4M
Revenue (TTM)
$39.5K
Net Income (TTM)
-$8.9M
Cash & Investments
$11.5M
Net Cash
$11.5M
Free Cash Flow (TTM)
-$7.4M
Operating CF (TTM)
-$7.4M
Debt/Equity
0.00
Cash Runway & Burn Rate
Cash on Hand
$11.5M
Quarterly Burn
$1.8M
Monthly Burn
$614.6K
Est. Runway
~6.3 quarters
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $187.0K | $40.0K | $941.0K | $15.7M | $16.5M | $4.1M | $8.0M | $4.3M | $4.2M | $11.5M | |
| Operating Cash Flow | -$870.0K | -$635.0K | -$609.0K | -$2.6M | -$6.6M | -$6.5M | -$6.7M | -$12.6M | -$4.0M | -$7.4M | |
| Free Cash Flow | -$870.0K | -$635.0K | -$609.0K | -$2.6M | -$6.6M | -$6.5M | -$6.7M | -$12.6M | -$4.0M | -$7.4M | |
| Capital Expenditure | $0.00 | $0.00 | $0.00 | -$10.0K | -$50.0K | -$6.0K | -$9.0K | -$13.0K | -$2.0K | -$5.0K | |
| Financing Cash Flow | $699.0K | $488.0K | $1.5M | $17.3M | $7.5M | $0.00 | $4.6M | $8.9M | $3.8M | $14.9M |
R&D Spending
R&D (TTM)
$2.4M
R&D Intensity
6002.5%
R&D Growth vs Prior
+108.7%
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $86.0K | $0.00 | $0.00 | $17.0K | $39.5K | |
| R&D Expense | $504.0K | $223.0K | $136.0K | $354.0K | $2.9M | $4.4M | $6.0M | $11.7M | $1.1M | $2.4M | |
| R&D % of Revenue | — | — | — | — | — | 5141.9% | — | — | 6682.4% | 6002.5% | |
| SG&A | $376.0K | $277.0K | $553.0K | $1.3M | $4.3M | $4.4M | $3.5M | $3.0M | $3.0M | $5.0M |
Income Statement
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $86.0K | $0.00 | $0.00 | $17.0K | $39.5K | |
| Cost of Revenue | $0.00 | $0.00 | $1.0K | $0.00 | $7.0K | $15.0K | $15.0K | $16.0K | $844.0K | $161.0K | |
| Gross Profit | $0.00 | $0.00 | -$1.0K | $0.00 | -$7.0K | $71.0K | -$15.0K | -$16.0K | -$827.0K | -$121.5K | |
| R&D | $504.0K | $223.0K | $136.0K | $354.0K | $2.9M | $4.4M | $6.0M | $11.7M | $1.1M | $2.4M | |
| SG&A | $376.0K | $277.0K | $553.0K | $1.3M | $4.3M | $4.4M | $3.5M | $3.0M | $3.0M | $5.0M | |
| Operating Income | -$880.0K | -$500.0K | -$689.0K | -$1.7M | -$7.2M | -$8.9M | -$9.6M | -$14.7M | -$5.0M | -$9.0M | |
| Interest Expense | $0.00 | $324.0K | $541.0K | $987.0K | $10.0K | $61.0K | $384.0K | $14.0K | $10.0K | $0.00 | |
| Pretax Income | -$1.1M | -$828.0K | -$1.3M | -$3.8M | -$7.2M | -$8.8M | -$9.3M | -$14.6M | -$5.0M | -$9.3M | |
| Net Income | -$2.1M | -$828.0K | -$1.8M | -$4.1M | -$7.2M | -$8.8M | -$9.3M | -$14.6M | -$4.8M | -$8.9M | |
| EPS (Diluted) | -906.25 | -1208.00 | -1552.86 | -2076.30 | -4430.82 | -4948.02 | -4283.23 | -804.00 | -7.47 | -11.16 | |
| EBITDA | $0.00 | -$3.0K | -$688.0K | -$1.7M | -$7.2M | -$8.8M | -$9.6M | -$14.6M | -$4.2M | -$7.4M | |
| Shares Out. (M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.65 | 1.24 |
Balance Sheet
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $187.0K | $40.0K | $941.0K | $15.7M | $16.5M | $4.1M | $8.0M | $4.3M | $4.2M | $8.5M | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.0M | |
| Total Current Assets | $213.0K | $80.0K | $972.0K | $17.8M | $19.0M | $12.3M | $9.8M | $4.4M | $4.4M | $11.9M | |
| Total Assets | $214.0K | $81.0K | $1.2M | $17.8M | $19.1M | $12.3M | $9.9M | $4.5M | $12.0M | $19.1M | |
| Total Current Liabilities | $135.0K | $18.0K | $6.3M | $961.0K | $757.0K | $1.1M | $2.4M | $2.4M | $2.4M | $2.3M | |
| Long-Term Debt | $3.7M | $4.5M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Liabilities | $3.8M | $4.5M | $6.8M | $1.2M | $991.0K | $1.3M | $2.7M | $2.7M | $2.7M | $2.6M | |
| Stockholders' Equity | -$3.6M | -$4.5M | -$5.6M | $16.6M | $18.1M | $11.0M | $7.2M | $1.8M | $8.5M | $15.9M | |
| Retained Earnings | -$10.3M | -$11.1M | -$12.4M | -$16.5M | -$23.7M | -$32.5M | -$41.9M | -$56.5M | -$61.3M | -$64.1M |
Cash Flow Statement
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$870.0K | -$635.0K | -$609.0K | -$2.6M | -$6.6M | -$6.5M | -$6.7M | -$12.6M | -$4.0M | -$7.4M | |
| Capital Expenditure | $0.00 | $0.00 | $0.00 | -$10.0K | -$50.0K | -$6.0K | -$9.0K | -$13.0K | -$2.0K | -$5.0K | |
| Free Cash Flow | -$870.0K | -$635.0K | -$609.0K | -$2.6M | -$6.6M | -$6.5M | -$6.7M | -$12.6M | -$4.0M | -$7.4M | |
| Investing Cash Flow | $0.00 | $0.00 | $0.00 | -$10.0K | -$50.0K | -$6.0M | $6.0M | -$13.0K | -$982.0K | -$3.4M | |
| Financing Cash Flow | $699.0K | $488.0K | $1.5M | $17.3M | $7.5M | $0.00 | $4.6M | $8.9M | $3.8M | $14.9M | |
| Issuance of Stock | $0.00 | $0.00 | $0.00 | $17.3M | $6.0M | $0.00 | $1.7M | $5.3M | $3.8M | $4.0M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $699.0K | $488.0K | $241.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $18.0K | $0.00 | $89.0K | $38.0K | $812.0K | $1.4M | $804.0K | $310.0K | $447.0K | $510.5K | |
| Net Change in Cash | -$171.0K | -$147.0K | $901.0K | $14.7M | $881.0K | -$12.5M | $3.9M | -$3.8M | -$105.0K | -$1.1M |
Dilution Tracker
Shares outstanding grew 33095.3% over 5 years — significant dilution
Shares Outstanding
0M
5-Year Share Growth
+33095.3%
Stock Issuance (TTM)
$4.0M
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.65 | 1.24 | |
| Change vs Prior % | — | 0.0% | -32.7% | 25.9% | -16.2% | 8.7% | 22.8% | 731.4% | 3471.7% | 92.1% | |
| Stock Issuance | $0.00 | $0.00 | $0.00 | $17.3M | $6.0M | $0.00 | $1.7M | $5.3M | $3.8M | $4.0M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $18.0K | $0.00 | $89.0K | $38.0K | $812.0K | $1.4M | $804.0K | $310.0K | $447.0K | $510.5K |
Margins & Profitability
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | — | — | — | — | — | 82.6% | — | — | -4864.7% | -307.6% | |
| Operating Margin % | — | — | — | — | — | -10312.8% | — | — | -29335.3% | -22873.4% | |
| Net Margin % | — | — | — | — | — | -10223.3% | — | — | -28458.8% | -22521.5% | |
| EBITDA Margin % | — | — | — | — | — | -10180.2% | — | — | -24782.4% | -18713.9% | |
| FCF Margin % | — | — | — | — | — | -7517.4% | — | — | -23276.5% | -18684.8% | |
| ROE % | 57.6% | 18.6% | 32.4% | -24.4% | -40.1% | -79.8% | -129.1% | -799.8% | -56.6% | -72.9% | |
| ROA % | -976.6% | -1022.2% | -156.4% | -22.8% | -38.0% | -71.3% | -94.1% | -322.4% | -40.3% | -46.6% | |
| ROIC % | -1113.9% | -793.7% | -69.0% | -9.9% | -39.4% | -78.7% | -126.5% | -689.5% | -52.1% | -53.8% | |
| R&D / Revenue % | — | — | — | — | — | 5141.9% | — | — | 6682.4% | 6002.5% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -100.0% | 0.0% | 0.0% | |
| Gross Profit | 0.0% | 0.0% | 0.0% | 100.0% | 0.0% | 1114.3% | -121.1% | -6.7% | -5068.8% | |
| Operating Income | 0.0% | 43.2% | -37.8% | -142.5% | -331.4% | -23.0% | -8.1% | -53.1% | 66.0% | |
| Net Income | 0.0% | 60.4% | -119.8% | -122.7% | -78.8% | -21.3% | -6.3% | -56.1% | 66.8% | |
| EPS (Diluted) | 0.0% | -33.3% | -28.5% | -33.7% | -113.4% | -11.7% | 13.4% | 81.2% | 99.1% | |
| Operating Cash Flow | 0.0% | 27.0% | 4.1% | -319.9% | -156.3% | 1.4% | -3.4% | -89.0% | 68.7% | |
| Free Cash Flow | 0.0% | 27.0% | 4.1% | -321.5% | -157.2% | 2.1% | -3.4% | -88.9% | 68.7% | |
| R&D Expense | 0.0% | -55.8% | -39.0% | 160.3% | 707.9% | 54.6% | 36.5% | 94.0% | -90.3% | |
| SG&A Expense | 0.0% | -26.3% | 99.6% | 138.2% | 230.1% | 2.3% | -20.2% | -16.8% | 2.4% | |
| Total Assets | 0.0% | -62.1% | 1337.0% | 1429.3% | 7.1% | -35.4% | -19.5% | -54.4% | 165.1% | |
| Book Value / Share | 0.0% | -22.8% | -85.4% | 334.9% | 29.9% | -43.9% | -46.5% | -97.0% | -85.7% | |
| Debt | 0.0% | 21.9% | 36.6% | -100.0% | 0.0% | 0.0% | 0.0% | -47.7% | -53.3% | |
| Diluted Shares | 0.0% | 0.0% | -32.7% | 25.9% | -16.2% | 8.7% | 22.8% | 731.4% | 3471.7% |
Valuation
P/E (TTM)At Loss
P/S1.78
P/B0.07
10Y Low / Med / High0.02 / 0.16 / 0.24
EV/EBITDA1.14
10Y Low / Med / High0.27 / 0.81 / 7.82
EV/Revenue-212.81
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$6.39
Tangible Book / Share
$7.51
Net Current Assets / Share
$115.07
Graham Net-Net
$7.17
Cash / Share
$9.27
| Metric | Trend | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -2.21 | -5.57 | -1.30 | -0.65 | -0.09 | -0.03 | -0.02 | -0.02 | -0.43 | -0.08 | |
| P/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.56 | 0.00 | 0.00 | 122.35 | 1.78 | |
| P/B Ratio | -1.27 | -1.03 | -0.56 | 0.16 | 0.04 | 0.02 | 0.02 | 0.17 | 0.24 | 0.07 | |
| EV/EBITDA | 0.00 | -3030.05 | -12.16 | 7.82 | 2.20 | 0.44 | 0.81 | 0.27 | 0.49 | 1.14 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -45.07 | 0.00 | 0.00 | -121.47 | -212.81 |
Analyst Estimates & Quality
Altman Z-Score
-5.63
Distress
Piotroski F-Score
3
Weak
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
| Revenue | $10.3M | $11.0M | $37.3M |
| Net Income | -$114.3M | -$84.0M | $12.4M |
| EPS | $-176.40 | $-129.60 | $19.20 |
| # Analysts (EPS) | 1 | 1 | 1 |